Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively
- PMID: 7678051
- PMCID: PMC358893
- DOI: 10.1128/mcb.13.1.133-143.1993
Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively
Abstract
Binding of platelet-derived growth factor (PDGF) to the PDGF receptor (PDGFR) beta subunit triggers receptor tyrosine phosphorylation and the stable association of a number of signal transduction molecules, including phospholipase C gamma (PLC gamma), the GTPase activating protein of ras (GAP), and phosphatidylinositol-3 kinase (PI3K). Previous reports have identified three PDGFR tyrosine phosphorylation sites in the kinase insert domain that are important for stable association of GAP and PI3K. Two of them, tyrosine (Y) 740, and Y-751 are required for the stable association of PI3K, while Y-771 is required for binding of GAP. Here we present data for two additional tyrosine phosphorylation sites, Y-1009 and Y-1021, that are both in the carboxy-terminal region of the PDGFR. Characterization of PDGFR mutants in which these phosphorylation sites are substituted with phenylalanine (F) indicated that Y-1021 and Y-1009 were required for the stable association of PLC gamma and a 64-kDa protein, respectively. An F-1009/F-1021 double mutant selectively failed to bind both PLC gamma and the 64-kDa protein, whereas all of the carboxy-terminal mutants bound wild-type levels of GAP and PI3K. The carboxy terminus encodes the complete binding site for PLC gamma, since a phosphorylated carboxy-terminal fusion protein selectively bound PLC gamma. To determine the biological consequences of failure to associate with PLC gamma, we measured PDGF-dependent inositol phosphate production and initiation of DNA synthesis. The PDGFR mutants that failed to associate with PLC gamma were not able to mediate the PDGF-dependent production of inositol phosphates. Since tyrosine phosphorylation of PLC gamma enhances its enzymatic activity, we speculated that PDGFR mutants that failed to activate PLC gamma were unable to mediate its tyrosine phosphorylation. Surprisingly, the F-1021 receptor mediated readily detectable levels of PDGF-dependent PLC gamma tyrosine phosphorylation. Thus, the production of inositol phosphates requires not only PLC gamma tyrosine phosphorylation but also its association with the PDGFR. Comparison of the mutant PDGFRs' abilities to initiate PDGF-dependent DNA synthesis indicated that failure to associate with PLC gamma and produce inositol phosphates diminished the mitogenic response by 30%. In contrast, preventing the PDGFR from binding the 64-kDa protein did not compromise PDGF-triggered DNA synthesis at saturating concentrations of PDGF. Thus, it appears that phosphorylation of the PDGFR at Y-1021 is required for the stable association of PLC gamma to the receptor's carboxy terminus, the production of inositol phosphates, and initiation of the maximal mitogenic response.
Similar articles
-
The GTPase-activating protein of Ras suppresses platelet-derived growth factor beta receptor signaling by silencing phospholipase C-gamma 1.Mol Cell Biol. 1995 Jun;15(6):3058-71. doi: 10.1128/MCB.15.6.3058. Mol Cell Biol. 1995. PMID: 7760802 Free PMC article.
-
Identification of residues in the beta platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-gamma 1.Oncogene. 1993 Sep;8(9):2493-9. Oncogene. 1993. PMID: 7689724
-
GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit.Mol Cell Biol. 1992 Jun;12(6):2534-44. doi: 10.1128/mcb.12.6.2534-2544.1992. Mol Cell Biol. 1992. PMID: 1375321 Free PMC article.
-
Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.Tumour Biol. 2016 Aug;37(8):10053-66. doi: 10.1007/s13277-016-5069-z. Epub 2016 May 19. Tumour Biol. 2016. PMID: 27193823 Review.
-
Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review.Int J Biol Macromol. 2022 Mar 31;202:539-557. doi: 10.1016/j.ijbiomac.2022.01.113. Epub 2022 Jan 21. Int J Biol Macromol. 2022. PMID: 35074329 Review.
Cited by
-
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.EMBO J. 2001 Jun 1;20(11):2768-78. doi: 10.1093/emboj/20.11.2768. EMBO J. 2001. PMID: 11387210 Free PMC article.
-
Growth factor-induced binding of dynamin to signal transduction proteins involves sorting to distinct and separate proline-rich dynamin sequences.EMBO J. 1994 Jun 1;13(11):2574-82. doi: 10.1002/j.1460-2075.1994.tb06547.x. EMBO J. 1994. PMID: 8013457 Free PMC article.
-
Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases.EMBO J. 1993 Jun;12(6):2257-64. doi: 10.1002/j.1460-2075.1993.tb05879.x. EMBO J. 1993. PMID: 7685273 Free PMC article.
-
The Multi-Kinase Inhibitor RepSox Enforces Barrier Function in the Face of Both VEGF and Cytokines.Biomedicines. 2023 Aug 31;11(9):2431. doi: 10.3390/biomedicines11092431. Biomedicines. 2023. PMID: 37760872 Free PMC article.
-
Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation.Mol Cell Biol. 1996 Dec;16(12):6926-36. doi: 10.1128/MCB.16.12.6926. Mol Cell Biol. 1996. PMID: 8943348 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous